Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBUPF.L Regulatory News (BUPF)

  • There is currently no data for BUPF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bupa announces price of Fixed & Subordinated Notes

18 Jun 2020 16:51

RNS Number : 4269Q
BUPA Finance PLC
18 June 2020
 

Bupa Finance PLCLEI Code: ZIMCVQHUFZ8GVHENP290

Bupa Finance plc announces the pricing of its offering of £300 million Fixed Rate Notes due 2027 and £350 million Fixed Rate Subordinated Notes due 2035

18 June 2020

Bupa (The British United Provident Association Limited), the international health insurer and provider, today announces that it has successfully launched and priced £300 million 1.750 per cent. fixed rate notes due 2027 (the "Senior Notes") and £350 million 4.125 per cent. fixed rate subordinated notes due 2035 (the "Tier 2 Notes") to be issued by its subsidiary, Bupa Finance plc. The Senior Notes are guaranteed by Bupa.

The Senior Notes are expected to be rated A3 and BBB+ by Moody's and Fitch respectively. The Tier 2 Notes are expected to be rated Baa1 (hyb) and BBB- by Moody's and Fitch respectively.

The Senior Notes were priced at a spread over gilts of 175 basis points and have a maturity date of 14 June 2027 and the Tier 2 Notes were priced at a spread over gilts of 375 basis points and have a maturity date of 14 June 2035. The transactions attracted strong demand from investors, with a combined orderbook at the final pricing of over £1.35bn and having peaked at over £1.65bn.

Bupa's Chief Financial Officer, Joy Linton said: "These bonds enable us to enhance Bupa's strong liquidity and capital positions and extend our debt maturity profile. We are very pleased with the continued demonstration of support from our fixed income investor base. We remain focused on continuing to improve our offer to our customers and growing sustainably over the long term in line with our Strategic Framework and Five-Year Vision."

For further information, please contact:

Investors

Investor Relations: ir@bupa.com

Media

 

Rupert Gowrley (Corporate Affairs): rupert.gowrley@bupa.com

 

DISCLAIMER

This announcement is for information purposes only and does not constitute an offer to sell or the solicitation of an offer to buy the Senior Notes and the Tier 2 Notes (together "the Notes") or any other security and shall not constitute an offer, solicitation or sale in the United States or in any jurisdiction in which, or to any persons to whom, such offering, solicitation or sale would be unlawful.

The Notes will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or any U.S. state securities laws, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the Notes will be only offered and sold to non-U.S. persons in offshore transactions outside the United States in accordance with Regulation S under the Securities Act.

Stabilisation in respect of the Notes may be conducted in accordance with FCA and International Capital Market Association Rules.

About Bupa

Bupa's purpose is helping people live longer, healthier, happier lives. With no shareholders, our customers are our focus. We reinvest profits into providing more and better healthcare for the benefit of current and future customers.

Health insurance accounts for the major part of our business with 17.5m customers and contributes 73% of revenue. We operate clinics, dental centres and hospitals in some markets, with 15.8m customers. We care for around 22,000 residents in our aged care businesses in the UK, Australia, New Zealand and Spain.

We directly employ around 83,000 people, principally in the UK, Australia, Spain, Chile, Poland, New Zealand, Hong Kong, Turkey, Brazil, the US, Middle East and Ireland. We also have associate businesses in Saudi Arabia and India.

For more information, visit www.bupa.com.

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IODBUGDLRSBDGGI
Date   Source Headline
2nd Mar 20237:00 amRNSBupa Finance 2022 Annual Report
4th Aug 20227:00 amRNSBupa Finance Announces Half Year Results
8th Mar 20227:00 amRNSBupa Finance plc 2021 Annual Report
27th Oct 20213:12 pmRNSPost Stabilisation Notice
24th Sep 20212:01 pmRNSFinal Issue and Tender Offer Results
23rd Sep 202110:28 amRNSIssue of Debt
22nd Sep 20211:49 pmRNSFinal Result Tender Offer Fixed Rate Sub Notes2023
22nd Sep 202110:55 amRNSIndicative Tender Offer Result
14th Sep 20219:34 amRNSTender Offer
5th Aug 20217:00 amRNSBupa Finance plc Half Year Report 2021
26th May 20214:09 pmRNSChange of Auditor
4th Mar 20217:00 amRNSAnnual Financial Report
7th Aug 20207:00 amRNSBupa Finance plc Half Year Report 2020
5th Aug 20202:34 pmRNSBupa to redeem £330m subordinated 2004 bonds
23rd Jun 20203:59 pmRNSBupa publishes Prospectuses for Note Offerings
18th Jun 20204:51 pmRNSBupa announces price of Fixed & Subordinated Notes
27th Apr 20201:39 pmRNSProspectuses: Uploaded to NSM
9th Apr 20201:13 pmRNSMoody’s affirms Bupa Insurance Limited’s Rating
31st Mar 202011:46 amRNSFitch downgrades Bupa Finance plc’s credit rating
5th Mar 20207:00 amRNSAnnual Financial Report
1st Aug 20197:00 amRNSBupa Finance Half Year Report 2019
14th Mar 20197:00 amRNSAnnual Financial Report
2nd Aug 20184:58 pmRNSHalf-year Report - Replacement
2nd Aug 20187:00 amRNSHalf-year Report
8th Mar 20187:04 amRNSAvailability of Annual Report
3rd Aug 20177:05 amRNSHalf-year Report
12th Apr 20179:22 amRNSPost-Stabilisation Notice - Bupa Finance
3rd Apr 20172:02 pmRNSBupa Finance plc publishes Prospectus
31st Mar 20177:00 amRNSBupa Finance plc £300m 2% Fixed Rate Note due 2024
30th Mar 20179:15 amRNSPre-Stabilisation Notice - BUPA
2nd Mar 20177:05 amRNSBupa Finance plc - Annual Financial Report 2016
10th Feb 20177:00 amRNSBupa completes acquisition of Oasis Dental Care
12th Dec 20161:24 pmRNSPost Stabilisation Notice - Bupa Finance plc
6th Dec 20163:05 pmRNSPublication of a Prospectus
2nd Dec 20167:00 amRNSPricing
1st Dec 201610:15 amRNSStabilisation Notice
18th Nov 20167:00 amRNSBupa to acquire Oasis Dental Care
4th Aug 20167:05 amRNSHalf-year Report
18th Mar 20161:32 pmRNSBupa Finance plc - Annual Financial Report 2015
13th Aug 20154:29 pmRNSBupa Finance plc - 2015 Half Year Report
24th Apr 201511:04 amRNSAnnual Financial Report
13th Jun 20144:40 pmRNSBupa Finance plc prospectus £350m 3.375% Notes
12th Jun 20147:00 amRNSChange of Auditor
29th Apr 20143:04 pmRNSAnnual Financial Report
30th Oct 20136:00 pmRNSRedemption of £100m 10.5per cent. Subord Bond 2018
6th Jun 20133:00 pmRNSPost Stabilisation - Bupa
23rd Apr 201312:49 pmRNSBupa Finance plc prospectus re £500m 5% Notes 2023
18th Apr 20139:14 amRNSStabilisation Notice - Bupa
26th Mar 201310:40 amRNSAnnual Financial Report
23rd Apr 20122:09 pmRNS2011 Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.